These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29903784)

  • 61. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
    Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adherence to oral HIV pre-exposure prophylaxis among female sex workers in Kampala, Uganda.
    Nalukwago GK; Isunju JB; Muwonge T; Katairo T; Bunani N; Semitala F; Kyambadde P; Matovu F
    Afr Health Sci; 2021 Sep; 21(3):1048-1058. PubMed ID: 35222566
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Where Do Female Sex Workers Seek HIV and Reproductive Health Care and What Motivates These Choices? A Survey in 4 Cities in India, Kenya, Mozambique and South Africa.
    Lafort Y; Greener R; Roy A; Greener L; Ombidi W; Lessitala F; Haghparast-Bidgoli H; Beksinska M; Gichangi P; Reza-Paul S; Smit JA; Chersich M; Delva W
    PLoS One; 2016; 11(8):e0160730. PubMed ID: 27494412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.
    Underhill K; Morrow KM; Colleran CM; Holcomb R; Operario D; Calabrese SK; Galárraga O; Mayer KH
    PLoS One; 2014; 9(11):e112425. PubMed ID: 25386746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.
    Ravasi G; Grinsztejn B; Baruch R; Guanira JV; Luque R; Cáceres CF; Ghidinelli M
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21113. PubMed ID: 27760687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. "Left behind": why implementing migration-aware responses to HIV for migrant farm workers is a priority for South Africa.
    Gruchy T; Vearey J
    Afr J AIDS Res; 2020 Mar; 19(1):57-68. PubMed ID: 32153239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project.
    Gomez GB; Eakle R; Mbogua J; Akpomiemie G; Venter WD; Rees H
    BMJ Open; 2016 Sep; 6(9):e011595. PubMed ID: 27678533
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
    Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
    J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities.
    Meyers K; Golub SA
    Curr Opin HIV AIDS; 2015 Jul; 10(4):290-5. PubMed ID: 26049956
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
    Bil JP; van der Veldt WM; Prins M; Stolte IG; Davidovich U
    Medicine (Baltimore); 2016 Sep; 95(39):e4910. PubMed ID: 27684827
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA; Atujuna M; Montgomery ET; Minnis A; Ndwayana S; Malapane T; Shapley-Quinn MK; Manenzhe K; Bekker LG; van der Straten A
    J Int AIDS Soc; 2018 Aug; 21(8):e25170. PubMed ID: 30152004
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: a mixed methods analysis.
    Robertson AM; Syvertsen JL; Martinez G; Rangel MG; Palinkas LA; Stockman JK; Ulibarri MD; Strathdee SA
    Glob Public Health; 2013; 8(5):619-33. PubMed ID: 23398385
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers.
    Syvertsen JL; Robertson Bazzi AM; Scheibe A; Adebajo S; Strathdee SA; Wechsberg WM
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):74-83. PubMed ID: 26050379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 78. When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
    Namey E; Agot K; Ahmed K; Odhiambo J; Skhosana J; Guest G; Corneli A
    Cult Health Sex; 2016 Sep; 18(9):1081-91. PubMed ID: 27093238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.
    Blaizot S; Huerga H; Riche B; Ellman T; Shroufi A; Etard JF; Ecochard R
    BMC Infect Dis; 2017 Jul; 17(1):522. PubMed ID: 28747167
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.